Related Experiment Video
Updated: May 12, 2026
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Statin use in giant cell arteritis: a retrospective study.
Jean Schmidt1, Tanaz A Kermani, Francesco Muratore
1Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
The Journal of Rheumatology
|April 3, 2013
Summary
Statin use was associated with a lower risk of developing giant cell arteritis (GCA). Statin use did not alter GCA presentation or disease progression in patients diagnosed with GCA.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Epidemiology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
- Statins are widely used for cardiovascular disease prevention.
- The relationship between statin use and GCA risk is not well-established.
Purpose of the Study:
- To investigate the association between statin use and the incidence of GCA.
- To compare the clinical characteristics and disease outcomes of GCA in statin users versus non-users.
Main Methods:
- Retrospective case-control study of biopsy-proven GCA patients diagnosed between 1998 and 2008.
- Matched controls were randomly selected from the general population.
- Statin exposure, clinical features, and disease course were analyzed.
Main Results:
- Statin use was less frequent in GCA patients (18.1%) compared to controls (33.3%).
- Statin users had a significantly lower risk of developing GCA (OR 0.31).
- Clinical presentation, disease activity, relapse rates, and survival were similar between GCA patients with and without statin use.
Conclusions:
- Statin use may be associated with a reduced risk of developing GCA.
- Statin therapy does not appear to influence the clinical presentation or disease course of established GCA.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...